Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorMichael Shy

About this trial

This is an observational longitudinal study to determine the natural history and genotype-phenotype correlations of disease causing mutations in Charcot Marie Tooth disease (CMT) type 1B (CMT1B), 2A (CMT2A), 4A (CMT4A), and 4C (CMT4C).

The investigators will also be determine the capability of the newly developed CMT Pediatric Scale (CMT Peds scale) and the Minimal Dataset to measure impairment and perform longitudinal measurements in patients with multiple forms of CMT over a five year window

Eligibility criteria

Qualifiers

Patient has documented, pathogenic or likely pathogenic CMT-causing variant(s)

Patient has a first- or second-degree family member (parent, child, sibling, half-sibling, aunt, uncle, grandparent, or grandchild) with a documented pathogenic or likely pathogenic CMT-causing variant AND a clear link between that family member and the affected patient AND a phenotype consistent with the diagnosis

Nerve conduction velocities: demyelinating, axonal, intermediate

Inheritance: dominant, recessive, X-linked, or unknown

Disqualifiers

Patient has a variant of uncertain significance that cannot be further classified following methods listed in the Inclusion Criteria.

Patient does not wish to be a part of the study or has not signed an informed consent form.

Patient is deemed inappropriate by the Site PI.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

5,000 Participants
are grouped into 5 trial groups

Sponsors and collaborators

Michael Shy

Lead sponsor

University of Iowa

Sponsor institution

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

Collaborator

Johns Hopkins University

Collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborator

King's College Hospital NHS Trust

Collaborator

Nemours Children's Hospital

Collaborator

Stanford University

Collaborator

University of Pennsylvania

Collaborator

University of Rochester

Collaborator

Children's Hospital of Philadelphia

Collaborator

Sydney Children's Hospitals Network

Collaborator

Rare Diseases Clinical Research Network

Collaborator

Muscular Dystrophy Association

Collaborator

National Institutes of Health (NIH)

Collaborator

Charcot-Marie-Tooth Association

Collaborator

Massachusetts General Hospital

Collaborator

Cedars-Sinai Medical Center

Collaborator

University of Miami

Collaborator

University of Minnesota

Collaborator

Connecticut Children's Medical Center

Collaborator

University of Colorado, Denver

Collaborator

The National Hospital for Neurology and Neurosurgery

Collaborator

Dubowitz Neuromuscular Centre

Collaborator